NCT03947060 is a clinical trial in Depth of Anesthesia Monitoring, sponsored by Cleveland Clinic Abu Dhabi.

Who is sponsoring NCT03947060?

NCT03947060 is sponsored by Cleveland Clinic Abu Dhabi.

What condition does NCT03947060 study?

NCT03947060 studies Depth of Anesthesia Monitoring.

Is NCT03947060 still recruiting?

NCT03947060 is currently completed. Last updated 15 July 2020.

Last reviewed 2020-07-15 · How we verify

NCT03947060

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Alternative Position for the SedLine® Sensor

Completed Last updated 15 July 2020

What this trial tests

trial in Depth of Anesthesia Monitoring in 40 participants. Completed in 1 April 2020.

Timeline

1 December 2019

Primary endpoint
29 February 2020

1 April 2020

Quick facts

Lead sponsor	Cleveland Clinic Abu Dhabi
Status	Completed
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 December 2019
Primary completion	29 February 2020
Estimated completion	1 April 2020
Sites	1 location across United Arab Emirates

Conditions studied

Depth of Anesthesia Monitoring — all drugs for Depth of Anesthesia Monitoring →

Sponsor

Cleveland Clinic Abu Dhabi

Who can join

18 and older, any sex, with Depth of Anesthesia Monitoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

SedLine® Brain Function Monitoring provides real-time insight into a patient's depth of anesthesia with bilateral data acquisition and processing of electroencephalogram (EEG) signals. Four active EEG leads collect data from the frontal lobe with a sensor position on the patient's forehead. Whenever a frontal approach for neurosurgical procedures is required or the frontal placement of the EEG is not indicated, it would not be possible to place the SedLine® . Numerous studies have analyzed the change of position and the application of alternative positions for other devices used in assessing the depth of anesthesia. Albeit, yet to date, there is no study that analyzed the application of alternative positions for the SedLine® sensor.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cleveland Clinic Abu Dhabi trials

Trials by the same sponsor.

NCT05267782 — Correlation Between New O3 Regional Oximetry, Electroencephalography and the Somatosensory Evoked Potential in Carotid E · unknown
NCT03636464 — Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03947060 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cleveland Clinic Abu Dhabi
Last refreshed: 15 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03947060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing